- Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
- Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
- Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
- Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
- Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
More ▼
Key statistics
On Friday, Prestige Consumer Healthcare Inc (PBH:NYQ) closed at 69.67, -7.49% below its 52-week high of 75.31, set on Mar 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 68.27 |
---|---|
High | 69.96 |
Low | 68.17 |
Bid | 69.20 |
Offer | 70.00 |
Previous close | 68.35 |
Average volume | 202.04k |
---|---|
Shares outstanding | 49.65m |
Free float | 49.05m |
P/E (TTM) | -- |
Market cap | 3.46bn USD |
EPS (TTM) | -1.64 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.
More ▼